JPMorgan downgraded InnovAge (INNV) to Underweight from Neutral with a $5 price target The company operates within a sensitive market and is subject to higher scrutiny from both state and federal regulators, which has presented an extended headwind to growth prospects over the past three years, the analyst tells investors in a research note. The firm cites lingering headwinds to InnovAge’s long-term growth prospects presented by regulatory scrutiny from both state and federal regulators for the downgrade.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INNV: